Form4insider filings, from the source

SEC Form 4 · accession 0001209191-16-121432

Atara Biotherapeutics, Inc. · ATRA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Mitchall G. Clark
Officer — Chief R & QA Officer
Period of report
May 16, 2016
Accepted (ET)
May 18, 2016 · 7:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001604464

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1May 16, 2016M7,212$0.00A87,912D
Common StockMay 16, 2016S4,153$15.15D83,759D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitesF3,F4,F5—May 16, 2016M7,212D——Common Stock7,21255,288D

Explanation of responses